[Skip to Content]
[Skip to Content Landing]
Views 71
Citations 0
Comment & Response
March 2018

Disagreement With the NICE Decision

Author Affiliations
  • 1Departments of Medicine and Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania
  • 2Louisville Cardiology Group at Baptist Health, Louisville, Kentucky
JAMA Intern Med. 2018;178(3):438-439. doi:10.1001/jamainternmed.2017.8661

To the Editor In an Invited Commentary1 accompanying our Original Investigation,2 both published in a recent issue of JAMA Internal Medicine, Villines and Shaw1 emphasize findings that they feel support the National Institute for Health and Care Excellence (NICE) decision to recommend coronary computed tomographic angiography (CCTA) as the initial test for patients with suspected coronary artery disease (CAD). Their argument focuses on the statistically significant reduction in myocardial infarction (MI). We disagree with their interpretation and conclusion.

First Page Preview View Large
First page PDF preview
First page PDF preview